Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity

No‐Joon Song(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ouliana Ziouzenkova(The Ohio State University)
Cells
January 26, 2022
10.3390/cells11030425
Cited by 11

Related Papers

Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein
|Translational Psychiatry|2018|38
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
|Cancer Discovery|2025|20
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers
|Cancer Discovery|2025|17